Concepedia
3
Publications
114
Citations
H-Index
2018
Active since
Affiliations
GlaxoSmithKline (United States)(Current)
Target (United States)
Alan V. McDougal is an author at GlaxoSmithKline (United States).
Publications per year
2018–2020
Sustained elevation of MG53 in the bloodstream increases tissue regenerative capacity without compromising metabolic function
Zehua Bian, Qiang Wang, Xinyu Zhou et al. · Nature Communications · 2019 · 65 citations · Full text
HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction-induced injury
Andrew N. Billin, Samuel E. Honeycutt, Alan V. McDougal et al. · Skeletal Muscle · 2018 · 31 citations · Full text
Complementary NAD+ replacement strategies fail to functionally protect dystrophin-deficient muscle
David W. Frederick, Alan V. McDougal, Melisa Semenas et al. · Skeletal Muscle · 2020 · 18 citations · Full text
Rows per page
1–3 of 3